Alembic Pharma Gets US FDA Establishment Inspection Report For Panelav Unit

Alembic Pharmaceuticals Ltd. has received an establishment inspection report from the US Food and Drug Administration for its formulation facility at Panelav in Gujarat, the company said in an exchange filing.

The US FDA conducted an inspection of the facility, which manufactures oncology injectables and oral solids, on October 7–8.

The report marks the completion of the inspection and confirms the facility’s compliance status, Alembic said.